Company profile ATRA
After 39 days of this quarter the interest is at 87.0. Based on that we can calculate that during remaining 52 days it will total up to 203.0. Atara Biotherapeutics expected interest is significantly lower compared to previous quarter (-42.7%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 280 | 420 50.0% QoQ | 757 80.2% QoQ | 288 -62.0% QoQ |
| 2020 | 429 53.2% YoY 49.0% QoQ | 514 22.4% YoY 19.8% QoQ | 276 -63.5% YoY -46.3% QoQ | 256 -11.1% YoY -7.2% QoQ |
| 2021 | 401 -6.5% YoY 56.6% QoQ | 337 -34.4% YoY -16.0% QoQ | 357 29.3% YoY 5.9% QoQ | 345 34.8% YoY -3.4% QoQ |
| 2022 | 269 -32.9% YoY -22.0% QoQ | 420 24.6% YoY 56.1% QoQ | 495 38.7% YoY 17.9% QoQ | 348 0.9% YoY -29.7% QoQ |
| 2023 | 274 1.9% YoY -21.3% QoQ | 238 -43.3% YoY -13.1% QoQ | 241 -51.3% YoY 1.3% QoQ | 354 1.7% YoY 46.9% QoQ |
| 2024 | 87 -68.2% YoY -75.4% QoQ | - | - | - |
The average 5 years interest of Atara Biotherapeutics was 28.3 per week. The last year interest of Atara Biotherapeutics compared to the last 5 years has changed by -28.9%. The interest for Atara Biotherapeutics is significantly decreasing. The last year interest is quite lower compared to 5 years ago. It has decreased by -44.82%.
There is not enough data for Tab-cel to provide analysis
There is not enough data for Tab-cel to provide correlation calculation
There is not enough data for Tab-cel to provide analysis
After 34 days of this quarter the interest is at 129.0. Based on that we can calculate that during remaining 58 days it will total up to 349.0. T-cell immunotherapy expected interest is significantly higher compared to previous quarter (+206.1%) and same quarter last year (+336.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 42 |
| 2019 | 80 90.5% QoQ | 31 -61.2% QoQ | 60 93.5% QoQ | 13 -69.0% YoY -78.3% QoQ |
| 2020 | 79 -1.2% YoY 507.7% QoQ | 23 -25.8% YoY -70.9% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 12 inf% YoY inf% QoQ | 137 inf% YoY 1041.7% QoQ | 40 inf% YoY -70.8% QoQ | 80 inf% YoY 100.0% QoQ |
| 2023 | 100 733.3% YoY 25.0% QoQ | 131 -4.4% YoY 31.0% QoQ | 114 185.0% YoY -13.0% QoQ | 129 61.2% YoY 13.2% QoQ |
The average 5 years interest of T-cell immunotherapy was 4.1 per week. The last year interest of T-cell immunotherapy compared to the last 5 years has changed by 141.95%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 141.95%.
After 39 days of this quarter the interest is at 105.0. Based on that we can calculate that during remaining 52 days it will total up to 245.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 78 | 134 71.8% QoQ | 158 17.9% QoQ | 151 -4.4% QoQ |
| 2020 | 160 105.1% YoY 6.0% QoQ | 163 21.6% YoY 1.9% QoQ | 169 7.0% YoY 3.7% QoQ | 132 -12.6% YoY -21.9% QoQ |
| 2021 | 148 -7.5% YoY 12.1% QoQ | 177 8.6% YoY 19.6% QoQ | 174 3.0% YoY -1.7% QoQ | 176 33.3% YoY 1.1% QoQ |
| 2022 | 451 204.7% YoY 156.2% QoQ | 260 46.9% YoY -42.4% QoQ | 238 36.8% YoY -8.5% QoQ | 244 38.6% YoY 2.5% QoQ |
| 2023 | 254 -43.7% YoY 4.1% QoQ | 241 -7.3% YoY -5.1% QoQ | 229 -3.8% YoY -5.0% QoQ | 243 -0.4% YoY 6.1% QoQ |
| 2024 | 105 -58.7% YoY -56.8% QoQ | - | - | - |
The average 5 years interest of Epstein-barr virus was 15.65 per week. The last year interest of Epstein-barr virus compared to the last 5 years has changed by 18.34%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 66.85%.
There is not enough data for Post-transplant lymphoproliferative disease to provide analysis
There is not enough data for Post-transplant lymphoproliferative disease to provide correlation calculation
There is not enough data for Post-transplant lymphoproliferative disease to provide analysis
After 39 days of this quarter the interest is at 156.0. Based on that we can calculate that during remaining 52 days it will total up to 364.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 343 | 575 67.6% QoQ | 515 -10.4% QoQ | 454 -11.8% QoQ |
| 2020 | 430 25.4% YoY -5.3% QoQ | 420 -27.0% YoY -2.3% QoQ | 535 3.9% YoY 27.4% QoQ | 513 13.0% YoY -4.1% QoQ |
| 2021 | 330 -23.3% YoY -35.7% QoQ | 514 22.4% YoY 55.8% QoQ | 472 -11.8% YoY -8.2% QoQ | 274 -46.6% YoY -41.9% QoQ |
| 2022 | 613 85.8% YoY 123.7% QoQ | 478 -7.0% YoY -22.0% QoQ | 501 6.1% YoY 4.8% QoQ | 383 39.8% YoY -23.6% QoQ |
| 2023 | 473 -22.8% YoY 23.5% QoQ | 481 0.6% YoY 1.7% QoQ | 541 8.0% YoY 12.5% QoQ | 541 41.3% YoY 0.0% QoQ |
| 2024 | 156 -67.0% YoY -71.2% QoQ | - | - | - |
The average 5 years interest of Nasopharyngeal carcinoma was 36.56 per week. The last year interest of Nasopharyngeal carcinoma compared to the last 5 years has changed by 3.72%. The interest for Nasopharyngeal carcinoma is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -5.93%.
After 39 days of this quarter the interest is at 173.0. Based on that we can calculate that during remaining 52 days it will total up to 404.0. CAR T immunotherapy expected interest is significantly higher compared to previous quarter (+82.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 268 | 261 -2.6% QoQ | 180 -31.0% QoQ | 259 43.9% QoQ |
| 2020 | 415 54.9% YoY 60.2% QoQ | 112 -57.1% YoY -73.0% QoQ | 162 -10.0% YoY 44.6% QoQ | 203 -21.6% YoY 25.3% QoQ |
| 2021 | 191 -54.0% YoY -5.9% QoQ | 267 138.4% YoY 39.8% QoQ | 179 10.5% YoY -33.0% QoQ | 163 -19.7% YoY -8.9% QoQ |
| 2022 | 163 -14.7% YoY 0.0% QoQ | 305 14.2% YoY 87.1% QoQ | 191 6.7% YoY -37.4% QoQ | 203 24.5% YoY 6.3% QoQ |
| 2023 | 312 91.4% YoY 53.7% QoQ | 282 -7.5% YoY -9.6% QoQ | 315 64.9% YoY 11.7% QoQ | 221 8.9% YoY -29.8% QoQ |
| 2024 | 173 -44.6% YoY -21.7% QoQ | - | - | - |
The average 5 years interest of CAR T immunotherapy was 18.49 per week. The last year interest of CAR T immunotherapy compared to the last 5 years has changed by 24.18%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 4.46%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Mesothelin expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 102 | 215 110.8% QoQ | 263 22.3% QoQ | 178 -32.3% QoQ |
| 2020 | 140 37.3% YoY -21.3% QoQ | 244 13.5% YoY 74.3% QoQ | 130 -50.6% YoY -46.7% QoQ | 168 -5.6% YoY 29.2% QoQ |
| 2021 | 120 -14.3% YoY -28.6% QoQ | 215 -11.9% YoY 79.2% QoQ | 207 59.2% YoY -3.7% QoQ | 167 -0.6% YoY -19.3% QoQ |
| 2022 | 198 65.0% YoY 18.6% QoQ | 249 15.8% YoY 25.8% QoQ | 212 2.4% YoY -14.9% QoQ | 89 -46.7% YoY -58.0% QoQ |
| 2023 | 107 -46.0% YoY 20.2% QoQ | 235 -5.6% YoY 119.6% QoQ | 154 -27.4% YoY -34.5% QoQ | 183 105.6% YoY 18.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Mesothelin was 13.7 per week. The last year interest of Mesothelin compared to the last 5 years has changed by -8.76%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -17.82%.
There is not enough data for B-cell malignancies to provide analysis
There is not enough data for B-cell malignancies to provide correlation calculation
There is not enough data for B-cell malignancies to provide analysis
After 34 days of this quarter the interest is at 232.0. Based on that we can calculate that during remaining 58 days it will total up to 628.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 211 inf% YoY inf% QoQ | 636 inf% YoY 201.4% QoQ | 623 inf% YoY -2.0% QoQ | 758 inf% YoY 21.7% QoQ |
| 2023 | 658 211.8% YoY -13.2% QoQ | 626 -1.6% YoY -4.9% QoQ | 604 -3.0% YoY -3.5% QoQ | 232 -69.4% YoY -61.6% QoQ |
The average 5 years interest of Multiple sclerosis was 16.66 per week. The last year interest of Multiple sclerosis compared to the last 5 years has changed by 199.4%. This is something to be checked. This didn't exist 5 years ago.